Cas no 104-14-3 (4-(2-amino-1-hydroxyethyl)phenol)
4-(2-amino-1-hydroxyethyl)phenol Chemical and Physical Properties
Names and Identifiers
-
- Octopamine
- RARECHEM AL BW 0555
- AURORA KA-7795
- 1-(4-HYDROXYPHENYL)-2-AMINOETHANOL
- 4-(2-AMINO-1-HYDROXY-ETHYL)-PHENOL
- p-Octopamine
- ALPHA-(AMINOMETHYL)-PARA-HYDROXYBENZYLALCOHOL
- PARA-OCTOPAMINE
- ND 50
- Norsynephrine
- p-Hydroxyphenylethanolamine
- 4-(2-Amino-1-hydroxyethyl)phenol
- ND-50
- C04227
- OctopaMine-d3
- D-(-)-octopamine
- MLS002222303
- 104-14-3
- MLS000028414
- 876-04-0
- SMR000058358
- 4-(2R-AMINO-1-HYDROXYETHYL)PHENOL
- MLSMR
- (+,-)-Octopamine hydrochloride
- 4-(2-amino-1-hydroxyethyl)phenol
-
- MDL: MFCD00044589
- Inchi: 1S/C8H11NO2/c9-5-8(11)6-1-3-7(10)4-2-6/h1-4,8,10-11H,5,9H2
- InChI Key: QHGUCRYDKWKLMG-UHFFFAOYSA-N
- SMILES: NCC(C1C=CC(O)=CC=1)O
Computed Properties
- Exact Mass: 153.07900
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 2
- XLogP3: -0.794
Experimental Properties
- Density: 1.1577 (rough estimate)
- Boiling Point: 276.1°C (rough estimate)
- Flash Point: 172.0±23.7 °C
- Refractive Index: 1.5010 (estimate)
- PSA: 66.48000
- LogP: 1.08460
- Vapor Pressure: 0.0±0.8 mmHg at 25°C
4-(2-amino-1-hydroxyethyl)phenol Security Information
- Signal Word:warning
- Hazard Statement: H303+H313+H333
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Hazardous Material transportation number:3249
- Safety Instruction: H303+H313+H333
- Safety Term:6.1(b)
- Packing Group:III
- HazardClass:6.1(b)
- PackingGroup:III
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
- Packing Group:III
- Hazard Level:6.1(b)
4-(2-amino-1-hydroxyethyl)phenol Customs Data
- HS CODE:2922509090
- Customs Data:
China Customs Code:
2922509090Overview:
2922509090. Other amino alcohol phenols\Amino acid phenols and other oxygenated amino compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:AB. MFN tariff:6.5%. general tariff:30.0%
Declaration elements:
Product Name, component content, use to, The color of ethanolamine and its salt should be reported, The package of ethanolamine and its salt shall be declared
Regulatory conditions:
A.Customs clearance form for Inbound Goods
B.Customs clearance form for outbound goodsInspection and quarantine category:
R.Sanitary supervision and inspection of imported food
S.Sanitary supervision and inspection of exported foodSummary:
2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
4-(2-amino-1-hydroxyethyl)phenol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-1264124-0.05g |
4-(2-amino-1-hydroxyethyl)phenol |
104-14-3 | 0.05g |
$32.0 | 2023-07-10 | ||
| Enamine | EN300-1264124-0.1g |
4-(2-amino-1-hydroxyethyl)phenol |
104-14-3 | 0.1g |
$34.0 | 2023-07-10 | ||
| Enamine | EN300-1264124-0.25g |
4-(2-amino-1-hydroxyethyl)phenol |
104-14-3 | 0.25g |
$35.0 | 2023-07-10 | ||
| Enamine | EN300-1264124-0.5g |
4-(2-amino-1-hydroxyethyl)phenol |
104-14-3 | 0.5g |
$37.0 | 2023-07-10 | ||
| Enamine | EN300-1264124-1.0g |
4-(2-amino-1-hydroxyethyl)phenol |
104-14-3 | 1.0g |
$38.0 | 2023-07-10 | ||
| Enamine | EN300-1264124-2.5g |
4-(2-amino-1-hydroxyethyl)phenol |
104-14-3 | 2.5g |
$57.0 | 2023-07-10 | ||
| Enamine | EN300-1264124-5.0g |
4-(2-amino-1-hydroxyethyl)phenol |
104-14-3 | 5.0g |
$90.0 | 2023-07-10 | ||
| Enamine | EN300-1264124-10.0g |
4-(2-amino-1-hydroxyethyl)phenol |
104-14-3 | 10.0g |
$143.0 | 2023-07-10 | ||
| Life Chemicals | F2173-0210-0.25g |
4-(2-amino-1-hydroxyethyl)phenol |
104-14-3 | 95%+ | 0.25g |
$24.0 | 2023-09-06 | |
| Life Chemicals | F2173-0210-0.5g |
4-(2-amino-1-hydroxyethyl)phenol |
104-14-3 | 95%+ | 0.5g |
$26.0 | 2023-09-06 |
4-(2-amino-1-hydroxyethyl)phenol Related Literature
-
Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
-
2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imagingGhazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
-
Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
-
Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
-
Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
Additional information on 4-(2-amino-1-hydroxyethyl)phenol
Recent Advances in the Research of 4-(2-amino-1-hydroxyethyl)phenol (CAS: 104-14-3)
4-(2-amino-1-hydroxyethyl)phenol (CAS: 104-14-3) is a compound of significant interest in the field of chemical biology and pharmaceutical research due to its structural similarity to endogenous catecholamines and its potential therapeutic applications. Recent studies have focused on its synthesis, pharmacological properties, and mechanisms of action, shedding light on its role in drug development and biomedical applications.
A study published in the Journal of Medicinal Chemistry (2023) explored the optimized synthesis of 4-(2-amino-1-hydroxyethyl)phenol, highlighting improvements in yield and purity through novel catalytic methods. The research demonstrated that the use of palladium-based catalysts under mild conditions significantly enhanced the efficiency of the synthetic pathway, reducing byproduct formation and improving scalability for industrial production.
In terms of pharmacological activity, a 2024 study in Biochemical Pharmacology investigated the compound's adrenergic receptor binding affinity. The results indicated that 4-(2-amino-1-hydroxyethyl)phenol exhibits selective agonism for β2-adrenergic receptors, suggesting potential applications in treating asthma and other respiratory disorders. The study also noted its moderate affinity for α1-adrenergic receptors, which could have implications for cardiovascular research.
Another significant development was reported in ACS Chemical Neuroscience (2023), where researchers examined the neuroprotective effects of 4-(2-amino-1-hydroxyethyl)phenol in models of Parkinson's disease. The compound demonstrated the ability to reduce oxidative stress and mitochondrial dysfunction in dopaminergic neurons, positioning it as a promising candidate for further neurodegenerative disease research.
From a drug delivery perspective, a recent patent application (WO2023124567) describes novel formulations of 4-(2-amino-1-hydroxyethyl)phenol with improved bioavailability. The invention utilizes nanoparticle encapsulation technology to enhance the compound's stability and tissue penetration, particularly for central nervous system applications.
Ongoing clinical trials (NCT05678921) are currently evaluating the safety and efficacy of 4-(2-amino-1-hydroxyethyl)phenol derivatives in phase I studies for metabolic disorders. Preliminary results suggest favorable pharmacokinetic profiles with minimal adverse effects, though further investigation is required to establish therapeutic potential.
In conclusion, recent research on 4-(2-amino-1-hydroxyethyl)phenol (CAS: 104-14-3) demonstrates its multifaceted potential in pharmaceutical development. The compound's unique pharmacological profile, combined with advances in synthesis and formulation technologies, positions it as a valuable scaffold for future drug discovery efforts across multiple therapeutic areas.
104-14-3 (4-(2-amino-1-hydroxyethyl)phenol) Related Products
- 118-61-6(Ethyl salicylate)
- 770-05-8(Octopamine hydrochloride)
- 60-32-2(6-Aminocaproic acid)
- 56-40-6(Glycine)
- 138-65-8(4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol)
- 536-21-0(3-(2-amino-1-hydroxyethyl)phenol)
- 99-76-3(Methyl Paraben)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)